A Restaging Transurethral Resection of the Bladder Is Always Necessary for High-grade T1 Non-muscle-invasive Bladder Cancer: Con

被引：3
|
作者：
Gontero, Paolo [1 ]
Livoti, Simone [1 ]
Soria, Francesco [1 ]
机构：
[1] Torino Sch Med, Dept Surg Sci, Div Urol, AOU Citta Salute & Sci Torino, Turin, Italy
来源：
EUROPEAN UROLOGY FOCUS | 2023年 / 9卷 / 04期
关键词：
D O I：
10.1016/j.euf.2023.03.009
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：559 / 560
页数：2
相关论文
共 50 条
  • [41] Current evidence for transurethral en bloc resection of non-muscle-invasive bladder cancer
    Kramer, Mario W.
    Abdelkawi, Islam F.
    Wolters, Mathias
    Bach, Thorsten
    Gross, Andreas J.
    Nagele, Udo
    Conort, Pierre
    Merseburger, Axel S.
    Kuczyk, Markus A.
    Herrmann, Thomas R. W.
    MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 2014, 23 (3-4) : 206 - 213
  • [42] Repeat transurethral resection for non-muscle-invasive bladder cancer: how are we going?
    Gendy, R.
    Delprado, W.
    Bariol, S.
    Brooks, A.
    Drummond, M.
    Lau, H.
    Wang, A.
    Patel, M.
    BJU INTERNATIONAL, 2013, 111 : 116 - 117
  • [43] Clinical rationale and safety of restaging transurethral resection in indication-stratified patients with high-risk non-muscle-invasive bladder cancer
    Zapala, Piotr
    Dybowski, Bartosz
    Poletajew, Slawomir
    Bialek, Lukasz
    Niewczas, Andrzej
    Radziszewski, Piotr
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2018, 16
  • [44] Clinical rationale and safety of restaging transurethral resection in indication-stratified patients with high-risk non-muscle-invasive bladder cancer
    Piotr Zapała
    Bartosz Dybowski
    Sławomir Poletajew
    Łukasz Białek
    Andrzej Niewczas
    Piotr Radziszewski
    World Journal of Surgical Oncology, 16
  • [45] Abnormal expression of multiple proteins predicts cancer-specific mortality in patients with high-grade non-muscle-invasive bladder cancer treated with transurethral resection
    Tsumura, Hideyasu
    Matsumoto, Kazumasa
    Sato, Yuichi
    Ikeda, Masaomi
    Fujita, Tetsuo
    Satoh, Takefumi
    Iwamura, Masatsugu
    MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (03) : 473 - 479
  • [46] Radiotherapy for High-grade T1 Bladder Cancer
    Raby, Sophie E. M.
    Choudhury, Ananya
    EUROPEAN UROLOGY FOCUS, 2018, 4 (04): : 506 - 508
  • [47] Predictive Factors for Residual Cancer in Second Transurethral Resection for Non-muscle-invasive Bladder Cancer
    Akitake, Masakazu
    Yamaguchi, Akito
    Shiota, Masaki
    Imada, Kenjiro
    Tatsugami, Katsunori
    Yokomizo, Akira
    Naito, Seiji
    Eto, Masatoshi
    ANTICANCER RESEARCH, 2019, 39 (08) : 4325 - 4328
  • [48] Timing of Second Resection in High-Grade Non-Muscle-Invasive Bladder Cancer - Does Delay Adversely Affect Outcome?
    Fitzpatrick, J.
    Biju, D. R.
    Amer, T.
    Hutton, R.
    Nair, B.
    BRITISH JOURNAL OF SURGERY, 2015, 102 : 119 - 119
  • [49] Considerations on the use of urine markers in the management of with high-grade non-muscle-invasive bladder cancer
    Kamat, Ashish M.
    Vlahou, Antonia
    Taylor, John A.
    Hudson, M'Liss A.
    Pesch, Beate
    Ingersoll, Molly A.
    Todenhoefer, Tilmann
    van Rhijn, Bas
    Kassouf, Wassim
    Grossman, H. Barton
    Behrens, Thomas
    Chandra, Ashish
    Goebell, Peter J.
    Palou, Juan
    Sanchez-Carbayo, Marta
    Schmitz-Draeger, Bernd J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (07) : 1069 - 1077
  • [50] Predicting progression in T1 non-muscle-invasive bladder cancer: back to histology
    Munari, Enrico
    Calio, Anna
    Brunelli, Matteo
    Martignoni, Guido
    BJU INTERNATIONAL, 2018, 122 (06) : 914 - 915
12345